Metabolomic Diagnostics is a deep-tech company at the forefront of developing innovative biomarker-based diagnostic solutions for complex diseases. With a strong and versatile IP portfolio, our focus is on identifying diagnostic biomarker panels and translating them into clinical assays. Our groundbreaking technology combines the biomarker multiplexing capabilities of Mass Spectrometry with our own informatics and statistics solutions to deliver diagnostic innovation.

We pride ourselves on operating at the interface of translational research and commercialization. Our multidisciplinary team collaborates closely with clinical research communities, mass spectrometry technology manufacturers, and clinical laboratories to ensure that our diagnostic solutions are fit-for-purpose. This dedication has earned us recognition in the life science industry, including being honored at the Life Science Industry Awards.

One area we're particularly passionate about is preeclampsia. In fact, May is Preeclampsia Awareness Month, and our research has contributed to the prediction of this condition using metabolite biomarkers. We're excited to continue making advancements in diagnostic technology and contributing to better healthcare outcomes.

Discover more about us and our innovative technology on our website